NZD/USD registers moderate losses as vaccine euphoria fades
|- NZD/USD dips as risk sentiment sours on coronavirus concerns.
- Rising cases overshadow optimism stemming from encouraging vaccine trials.
- Dovish Federal Reserve expectations restrict losses in Kiwi.
NZD/USD is flashing red on Tuesday as concerns over rising coronavirus cases and prospects of fresh lockdowns dampen the euphoria from vaccine trial breakthroughs.
The pair is currently trading near 0.6885, representing a 0.10% drop on the day, having declined from 0.6919 to 0.6875 on Tuesday. The latest weakness in the Kiwi is accompanied by a pullback in the New Zealand bond yields. The 10-year yield is currently trading at 0.85%, down three basis points on the day, having reached a high of 0.92% on Tuesday.
Risk-off
Risk sentiment has soured with the rising number of coronavirus cases in the US, across Europe, and in some Asian nations. Notably, more than 70,000 Americans were hospitalized for treatment of COVID-19 on Monday, forcing authorities to restrict gatherings and made face masks. That has revived fears of fresh lockdowns, which brought the US and global economy to a near standstill in the second quarter.
As such, Kiwi, AUD and other risk assets such as equities are losing ground. However, so far, losses have been moderate as the recent announcements of positive results of experimental vaccines by drugmakers Pfizer and Moderna have boosted speculation of a swift economic recovery in 2021. Also, the downside in NZD remains supported by hopes that the Federal Reserve (Fed) would do the heavy lifting to compensate for the US Congress' inability to deliver the fiscal stimulus. The Fed recently expressed a willingness to do more if needed.
Should the risk aversion worsen, the NZD/USD pair would suffer a deeper pullback. That possibility cannot be ruled out, as stocks seem to have run ahead of themselves in pricing a vaccine-driven economic recovery.
Technical levels
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.